在职业医学环境中联合药物和行为疗法戒烟的经济评价。
Economic Evaluation of Combining Pharmaco- and Behavioral Therapies for Smoking Cessation in an Occupational Medicine Setting.
机构信息
Health Economics and Outcomes Research Department (Dr Rejas-Gutiérrez); Trial Form Support Develop, Madrid (Dr López-Ibáñez de Aldecoa); Occupational Health and Risks Prevention Service (Ms Casasola, Dr Arriaza), Pfizer, SLU, Alcobendas; Human Resources and Risks Prevention Area (Dr Varela); and Labour Health and Risks Prevention Service (Ms Quesada, Dr Olive), Hospital Clinic, Barcelona, Spain.
出版信息
J Occup Environ Med. 2019 Apr;61(4):318-327. doi: 10.1097/JOM.0000000000001546.
OBJECTIVE
To estimate the budget impact (BI) of funding pharmaco+behavioral therapies for smoking cessation from an employer perspective.
METHODS
A hybrid economic model was applied to estimate the BI, which considered up to four cessation attempts over a 3-year horizon. The model estimated the costs of funding a cessation programme, and the mean savings due to avoided loss of productivity and absenteeism because of smoking cessation.
RESULTS
53.8% of smokers quit smoking. The programme, which costs &OV0556;394,468, would generate earnings of &OV0556;1,342,133; with &OV0556;644,974 in incremental net savings. These mean &OV0556;1.64 in return per each euro invested. Results show net benefits from two cigarettes smoked while working every day.
CONCLUSIONS
Considering the avoided costs of loss of productivity and absenteeism, funding a smoking cessation programme of pharmaco+behavioral therapies would produce substantial savings for the employer.
目的
从雇主角度估算为戒烟提供药物+行为疗法的预算影响。
方法
采用混合经济模型估算预算影响，该模型考虑了在 3 年内最多进行 4 次戒烟尝试。该模型估算了戒烟计划的成本，以及因戒烟而避免的生产力损失和旷工的平均节省。
结果
53.8%的吸烟者戒烟。该计划耗资 394,468 欧元，将产生 1,342,133 欧元的收益，增量净储蓄为 644,974 欧元。这意味着每投资 1 欧元可获得 1.64 欧元的回报。结果表明，每天工作时吸两支烟可获得净收益。
结论
考虑到生产力损失和旷工的避免成本，为药物+行为疗法的戒烟计划提供资金将为雇主带来巨大的节省。
Zotero 插件